HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

James A Miller Selected Research

of Leigh infantile subacute Necrotizing encephalopathy

8/20111,3-Dinitrobenzene-induced metabolic impairment through selective inactivation of the pyruvate dehydrogenase complex.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


James A Miller Research Topics

Disease

4Neoplasms (Cancer)
10/2021 - 02/2015
2Parkinson Disease (Parkinson's Disease)
02/2015 - 04/2013
1Thymoma (Thymic Carcinoma)
10/2021
1Melanoma (Melanoma, Malignant)
12/2020
1Lipodystrophy
12/2020
1Acinar Cell Carcinoma
09/2019
1Mucoepidermoid Tumor
09/2019
1Carcinoma (Carcinomatosis)
09/2019
1Adenoid Cystic Carcinoma (Cylindroma)
09/2019
1Squamous Cell Neoplasms (Squamous Cell Cancer)
01/2019
1Adenocarcinoma
01/2019
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2019
1Esophageal Neoplasms (Esophageal Cancer)
01/2019
1Granuloma
01/2019
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2019
1Congenital Abnormalities (Deformity)
03/2018
1Pneumonia (Pneumonitis)
01/2018
1Starvation
01/2017
1Hypoxia (Hypoxemia)
01/2017
1Head and Neck Neoplasms (Head and Neck Cancer)
01/2015
1Wounds and Injuries (Trauma)
07/2013
1Glioma (Gliomas)
08/2011
1Thiamine Deficiency
08/2011
1of Leigh infantile subacute Necrotizing encephalopathy
08/2011
1Neuroinflammatory Diseases
03/2011
1Shock
08/2010

Drug/Important Bio-Agent (IBA)

21- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
02/2015 - 03/2011
1CateninsIBA
10/2021
1Cadherins (E-Cadherin)IBA
10/2021
1AntibodiesIBA
10/2021
1Immune Checkpoint InhibitorsIBA
12/2020
15'-N-methylcarboxamideadenosineIBA
09/2019
1Tumor Necrosis Factor InhibitorsIBA
01/2019
1Probenecid (Benemid)FDA LinkGeneric
02/2015
1Cetuximab (Erbitux)FDA Link
01/2015
1Oxidoreductases (Dehydrogenase)IBA
08/2011
1Thiamine (Aneurin)FDA Link
08/2011
13-dinitrobenzeneIBA
08/2011
1Indicators and Reagents (Reagents)IBA
03/2011
1tert-ButylhydroperoxideIBA
08/2010
11,3-butadiene (divinyl)IBA
08/2010
1Hydroxyl RadicalIBA
08/2010
1hydroxide ionIBA
08/2010

Therapy/Procedure

2Therapeutics
12/2020 - 01/2015
1Immunotherapy
12/2020
1Drug Therapy (Chemotherapy)
01/2019
1Esophagectomy
01/2019
1Neoadjuvant Therapy
01/2019
1Pedicle Screws
03/2018
1Length of Stay
01/2018
1Operative Time
09/2017
1Resuscitation
01/2017
1Ambulatory Care (Outpatient Care)
07/2013
1Oral Administration
04/2013
1Dye Lasers
08/2010